Eleven Biotherapeutics, Inc – EBIO

Eleven Biotherapeutics, EBIO, is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics.

245 First Street, Suite 1800
Cambridge, MA 02142
Phone: (617) 444-8550
Email: info@elevenbio.com
Website: http://www.elevenbio.com/
EBIO SEC Filings

Healthcare | Biotechnology | USA



finviz dynamic chart for  EBIO


Author: ZitroStocks

Welcome to ZitroStocks, hope you enjoy your visit. You are welcome to ask questions and participate in discussions.

2 thoughts on “Eleven Biotherapeutics, Inc – EBIO”

Leave a Reply

Your email address will not be published. Required fields are marked *